24 related articles for article (PubMed ID: 8496836)
1. Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals.
Kim JC; Park EJ; Na DH
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559036
[TBL] [Abstract][Full Text] [Related]
2. A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development.
Martinez MN; Wu F; Sinko B; Brayden DJ; Grass M; Kesisoglou F; Stewart A; Sugano K
AAPS J; 2022 May; 24(3):61. PubMed ID: 35501528
[TBL] [Abstract][Full Text] [Related]
3. Approaches for enhancing oral bioavailability of peptides and proteins.
Renukuntla J; Vadlapudi AD; Patel A; Boddu SH; Mitra AK
Int J Pharm; 2013 Apr; 447(1-2):75-93. PubMed ID: 23428883
[TBL] [Abstract][Full Text] [Related]
4. Disruption of epithelial tight junctions by yeast enhances the paracellular delivery of a model protein.
Fuller E; Duckham C; Wood E
Pharm Res; 2007 Jan; 24(1):37-47. PubMed ID: 16969693
[TBL] [Abstract][Full Text] [Related]
5. Absorption-enhancing effects of sodium caprate and palmitoyl carnitine in rat and human colons.
Shimazaki T; Tomita M; Sadahiro S; Hayashi M; Awazu S
Dig Dis Sci; 1998 Mar; 43(3):641-5. PubMed ID: 9539662
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of nasal salmon calcitonin absorption by lauroylcarnitine chloride in rats.
Kagatani S; Shinoda T; Fukui M; Ohmura T; Hasumi S; Sonobe T
Pharm Res; 1996 May; 13(5):739-43. PubMed ID: 8860430
[TBL] [Abstract][Full Text] [Related]
7. Acylcarnitines in intermediary metabolism.
Sewell AC; Böhles HJ
Eur J Pediatr; 1995 Nov; 154(11):871-7. PubMed ID: 8582396
[TBL] [Abstract][Full Text] [Related]
8. Enhanced bioavailability of cefoxitin using palmitoylcarnitine. II. Use of directly compressed tablet formulations in the rat and dog.
Sutton SC; LeCluyse EL; Engle K; Pipkin JD; Fix JA
Pharm Res; 1993 Oct; 10(10):1516-20. PubMed ID: 8272416
[TBL] [Abstract][Full Text] [Related]
9. Transport and metabolic effects of carnitine and acylcarnitines in brain.
Nałecz KA; Nałecz MJ
Acta Biochim Pol; 1993; 40(3):337-43. PubMed ID: 8249490
[No Abstract] [Full Text] [Related]
10. In vitro effects of long-chain acylcarnitines on the permeability, transepithelial electrical resistance and morphology of rat colonic mucosa.
Lecluyse EL; Sutton SC; Fix JA
J Pharmacol Exp Ther; 1993 May; 265(2):955-62. PubMed ID: 8496836
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous in vitro measurement of intestinal tissue permeability and transepithelial electrical resistance (TEER) using Sweetana-Grass diffusion cells.
Sutton SC; Forbes AE; Cargill R; Hochman JH; LeCluyse EL
Pharm Res; 1992 Mar; 9(3):316-9. PubMed ID: 1614963
[TBL] [Abstract][Full Text] [Related]
13. Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability.
Suzuki T; Yoshida S; Hara H
Br J Nutr; 2008 Aug; 100(2):297-305. PubMed ID: 18346306
[TBL] [Abstract][Full Text] [Related]
14. Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis.
Yamada T; Fujimoto K; Tso P; Fujimoto T; Gaginella TS; Grisham MB
J Pharmacol Exp Ther; 1992 Jan; 260(1):313-8. PubMed ID: 1731045
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
